| Dr Victor Pang, MD | |
|
561 Medical Drive, Clarksdale, MS 38614 | |
| (662) 627-5256 | |
| Not Available |
| Full Name | Dr Victor Pang |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 40 Years |
| Location | 561 Medical Drive, Clarksdale, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396840922 | NPI | - | NPPES |
| 00115413 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 10725 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Mississippi Medical Center | Clarksdale, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cooper - Pang Eye Clinic Pa | 9638299787 | 2 |
News Archive
Scientists in the United States have genetically engineered normal immune cells to become specialized fighters and used them to attack cancerous tumours.
Four years after the hurricanes of 2005, four March of Dimes Mom & Baby Mobile Health Centers(R) serve as the primary health care providers for thousands of pregnant women, teenagers and children living along the Gulf Coast.
Children rarely get heart attacks – but the way their habits develop can play a crucial role in reducing their future chances of having heart disease. A new study presented at the Brazilian Congress of Cardiology (SBC 2019) on September 21, 2019, shows that school projects encouraging a better diet and more activity can reduce such deaths.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart failure, sinus rhythm, and coronary artery disease, according to late breaking results from the COMMANDER HF trial presented today in a Hot Line Session at ESC Congress 2018 and with simultaneous publication in NEJM.
› Verified 4 days ago
| Entity Name | Cooper - Pang Eye Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801989322 PECOS PAC ID: 9638299787 Enrollment ID: O20111207000478 |
News Archive
Scientists in the United States have genetically engineered normal immune cells to become specialized fighters and used them to attack cancerous tumours.
Four years after the hurricanes of 2005, four March of Dimes Mom & Baby Mobile Health Centers(R) serve as the primary health care providers for thousands of pregnant women, teenagers and children living along the Gulf Coast.
Children rarely get heart attacks – but the way their habits develop can play a crucial role in reducing their future chances of having heart disease. A new study presented at the Brazilian Congress of Cardiology (SBC 2019) on September 21, 2019, shows that school projects encouraging a better diet and more activity can reduce such deaths.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart failure, sinus rhythm, and coronary artery disease, according to late breaking results from the COMMANDER HF trial presented today in a Hot Line Session at ESC Congress 2018 and with simultaneous publication in NEJM.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Victor Pang, MD 561 Medical Drive, Clarksdale, MS 38614 Ph: (662) 627-5256 | Dr Victor Pang, MD 561 Medical Drive, Clarksdale, MS 38614 Ph: (662) 627-5256 |
News Archive
Scientists in the United States have genetically engineered normal immune cells to become specialized fighters and used them to attack cancerous tumours.
Four years after the hurricanes of 2005, four March of Dimes Mom & Baby Mobile Health Centers(R) serve as the primary health care providers for thousands of pregnant women, teenagers and children living along the Gulf Coast.
Children rarely get heart attacks – but the way their habits develop can play a crucial role in reducing their future chances of having heart disease. A new study presented at the Brazilian Congress of Cardiology (SBC 2019) on September 21, 2019, shows that school projects encouraging a better diet and more activity can reduce such deaths.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart failure, sinus rhythm, and coronary artery disease, according to late breaking results from the COMMANDER HF trial presented today in a Hot Line Session at ESC Congress 2018 and with simultaneous publication in NEJM.
› Verified 4 days ago
Dr. Tom Cooper, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 561 Medical Dr, Clarksdale, MS 38614 Phone: 662-627-5256 | |
Dr. Evelyn Lucile Massey, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 500 Chris Rd, Clarksdale, MS 38614 Phone: 662-645-4545 Fax: 662-358-4407 |